bpc-157 local injection near injury site evidence Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or Stable Gastric Pentadecapeptide BPC 157
Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle to Bone Reattachment in Rats BPC 157 for Injury Recovery and Gut Health: A Regenerative Peptide with Strong Potential Frontiers Stable Gastric Pentadecapeptide BPC 157 and Wound Healing BPC 157: Benefits, Dosing & Side Effects (2026)
Pay in 4 interest-free payments of $6.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 1 - Aug 6



